RESUMEN
The case of a 16-year old Jamaican girl who presented to the psychiatric service of a general hospital with features of Capgras syndrome is presented. Her history, treatment, progress and relevant psychodynamic and neurocognitive issues are explored. This is the first known published case of an adolescent with Capgras syndrome from the Caribbean. The case highlights that the syndrome may occur in different cultural contexts and that clinicians should be sensitive to its existence in order to avert under-diagnosis or misdiagnosis.
Asunto(s)
Benzodiazepinas/administración & dosificación , Síndrome de Capgras , Depresión , Dibenzotiazepinas/administración & dosificación , Sertralina/administración & dosificación , Adolescente , Antidepresivos/administración & dosificación , Antipsicóticos/administración & dosificación , Síndrome de Capgras/diagnóstico , Síndrome de Capgras/tratamiento farmacológico , Síndrome de Capgras/psicología , Región del Caribe , Depresión/diagnóstico , Depresión/tratamiento farmacológico , Relación Dosis-Respuesta a Droga , Relaciones Familiares , Femenino , Humanos , Pruebas Neuropsicológicas , Olanzapina , Escalas de Valoración Psiquiátrica , Fumarato de Quetiapina , Inducción de Remisión , Ideación Suicida , Resultado del TratamientoRESUMEN
The case of a 16-year old Jamaican girl who presented to the psychiatric service of a general hospital with features of Capgras syndrome is presented. Her history, treatment, progress and relevant psychodynamic and neurocognitive issues are explored. This is the first known published case of an adolescent with Capgras syndrome from the Caribbean. The case highlights that the syndrome may occur in different cultural contexts and that clinicians should be sensitive to its existence in order to avert under-diagnosis or misdiagnosis.
Se presenta el caso de una joven jamaicana de 16 años que acudió al servicio de psiquiatría de un hospital general con los rasgos del síndrome de Capgras. Se explora su historia, tratamiento, progreso, problemas neurocognitivos y psicodinámicos relevantes. Éste es el primer caso publicado de que se tenga noticias, de una adolescente con el síndrome de Capgras en la región del Caribe. El caso pone de relieve que el síndrome puede ocurrir en diferentes contextos culturales, y que los médicos deben de estar sensibilizados con su existencia a fin de evitar un subdiagnóstico o un diagnóstico erróneo.
Asunto(s)
Humanos , Femenino , Adolescente , Síndrome de Capgras/diagnóstico , Escalas de Valoración Psiquiátrica , Antipsicóticos/administración & dosificación , Benzodiazepinas/administración & dosificación , Inducción de Remisión , Síndrome de Capgras/tratamiento farmacológico , Resultado del Tratamiento , Relación Dosis-Respuesta a Droga , Ideación Suicida , Antidepresivos/administración & dosificación , Pruebas NeuropsicológicasRESUMEN
Reports of an 18-fold higher incidence of schizophrenia among second-generation Afro-Caribbeans, and especially Jamaican migrants in the United Kingdom were soon called "an epidemic of schizophrenia," with the inference that a novel virus, likely to be perinatally transmitted, was a possible etiological agent. This intriguing observation led us to explore a possible link with human T-cell lymphotropic virus type one (HTLV-I), because it is a virus that is endemic in the Caribbean Island, is perinatally transmitted, known to be neuropathogenic, and the cause of a chronic myelopathy (tropical spastic paraparesis/HTLV-I associated myelopathy. We therefore examined inpatients as the Bellevue Mental Hospital, Kingston, Jamaica and did standard serological tests for retroviruses HTLV-I and HTLV-II and HIV-I and HIV-II on 201 inpatients who fulfilled ICD-9 and DSM III-R criteria for schizophrenia. Our results produced important negative data, since the seropositivity rates for HTLV-I, the most likely pathogen, were no greater than the seropositivity range for HTLV-I carriers in this island population, indicating the HTLV-1 and the other retroviruses tested do not play a primary etiological role in Jamaican schizophrenics.
